BIOL (BIOLASE Inc.) רווחיות מכירות לפי רווח גולמי

BIOLASE, Inc. (BIOL) is a recognized global benchmark in the dental laser segment with high physician loyalty. Analyzing the gross income metric in GURU.Markets, we note that 34.30 reflects the level of this metric. Waterlase technology makes treatment painless, attracting premium clinics; however, market conservatism and the risk of delisting due to losses force the company to conduct secondary offerings.
פילוחי מדדים מקיפים ואנליטיקה עבור BIOLASE, Inc. (BIOL)

Fundamental risks for BIOLASE, Inc. (BIOL) are determined by the company's ability to maintain high profitability during the precision assembly of dental lasers and compliance with RoHS environmental directives. Gross margin measures the portion of revenue remaining after covering direct production costs, allowing for an assessment of cost management efficiency. Analyzing the company's gross profit margin helps investors identify deviations from market standards and forecast the sustainability of bottom-line profit.